Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...

The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the […] (Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

Why, then, are indices of implied — that is expected — stock and bond volatility so low? Some content could not load. Check ...

Elevance Health led the insurance sector higher after it beat Wall Street’s sales and profit targets and raised its dividend.

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC)... Investing.com ...

While Cigna, the parent company of Express Scripts, did not comment on the matter, CVS and UnitedHealth Group did. In a statement to Fortune, UnitedHealth Group said that it had assisted eligible ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...